671
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Brief overview of selected approaches in targeting pancreatic adenocarcinoma

& , PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ruth Nussinov, Serena Muratcioglu, Chung-Jung Tsai, Hyunbum Jang, Attila Gursoy & Ozlem Keskin. (2016) K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?. Expert Opinion on Therapeutic Targets 20:7, pages 831-842.
Read now

Articles from other publishers (4)

Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta & Akash Chaurasiya. (2021) Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview. International Immunopharmacology 95, pages 107508.
Crossref
Cheng-Jeng Tai, Ming-Te Huang, Chih-Hsiung Wu, Chien-Kai Wang, Chen-Jei Tai, Chun-Chao Chang, Cheng-I. Hsieh, Yu-Jia Chang, Chang-Jer Wu, Li-Jen Kuo, Po-Lei Wei, Ray-Jade Chen & Hung-Yi Chiou. (2016) Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma. Medicine 95:15, pages e3259.
Crossref
Orianne Olivares & Sophie Vasseur. (2016) Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze. International Journal of Cancer 138:4, pages 787-796.
Crossref
Rahul Kushwah, Borhane Guezguez, Jung Bok Lee, Claudia I Hopkins & Mickie Bhatia. (2014) Pleiotropic roles of Notch signaling in normal, malignant, and developmental hematopoiesis in the human. EMBO reports 15:11, pages 1128-1138.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.